谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 655 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Deleterious Biological Effects of Endocrine Disruptors: an Insight into Human Health Risks
Abdullah Al Lawati, Lubna Al Hashmi,Husain Al Aswami, Abdulrahman Al Hadhrami,Kok-Yong Chin,Srinivasa Rao Sirasanagandla,Srijit Das
Endocrine, metabolic & immune disorders drug targetsno. 13 (2024): 1471-1479
引用0浏览0WOS引用
0
0
Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus
Alsalt Al-Busaidi, Omer Alabri, Jaifar Alomairi, Ahmed ElSharaawy,Abdullah Al Lawati, Hanan Al Lawati,Srijit Das
Current diabetes reviewsno. 1 (2024): e170124225723-e170124225723
引用0浏览0WOS引用
0
0
Association of MiRNA and Bone Tumors: Future Therapeutic Inroads
Rashid Al-Shibli, Mohammed AlSuleimani, Ibrahim Ahmed,Abdullah Al Lawati,Srijit Das
Current Medicinal Chemistry (2024)
引用0浏览0WOS引用
0
0
Physicochemistry, Nutritional, and Therapeutic Potential of Ficus Carica – A Promising Nutraceutical
Muhammad Fattah Fazel,Izuddin Fahmy Abu,Mohamad Haiqal Nizar Mohamad, Noor Arniwati Mat Daud,Ahmad Najib Hasan, Zainie Aboo Bakkar, Muhammad Alif Naim Md Khir,Norsham Juliana,Srijit Das, Muhamad Razin Mohd Razali, Nurul Hana Zainal Baharin, Arashidatul Akmar Ismail
Drug design, development and therapy (2024): 1947-1968
引用0浏览0WOS引用
0
0
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma
Khalid Al Balushi, Abdulrahman Al Hadhrami, Hamdan Al Balushi,Abdullah Al Lawati,Srijit Das
Current drug targetsno. 3 (2024): 149-157
引用1浏览0WOS引用
1
0
加载更多
作者统计

#Papers: 655

#Citation: 9108

H-Index: 38

G-Index: 59

Sociability: 7

Diversity: 4

Activity: 102

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn